Detalles de la búsqueda
1.
Use and outcomes of dual antiplatelet therapy for acute coronary syndrome in patients with chronic kidney disease: insights from the Canadian Observational Antiplatelet Study (COAPT).
Heart Vessels
; 37(8): 1291-1298, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35089380
2.
Use of antithrombotic therapy for secondary prevention in patients with stable atherosclerotic cardiovascular disease: Insights from the COordinated National Network to Engage Cardiologists in the antithrombotic Treatment of patients with CardioVascular Disease (CONNECT-CVD) study.
Int J Clin Pract
; 75(10): e14597, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34228865
3.
Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC).
Am Heart J
; 198: 152-159, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29653637
4.
Impact of an invasive strategy in the elderly hospitalized with acute coronary syndrome with emphasis on the nonagenarians.
Catheter Cardiovasc Interv
; 92(7): E441-E448, 2018 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30269415
5.
Baseline characteristics, adenosine diphosphate receptor inhibitor treatment patterns, and in-hospital outcomes of myocardial infarction patients undergoing percutaneous coronary intervention in the prospective Canadian Observational AntiPlatelet sTudy (COAPT).
Am Heart J
; 181: 26-34, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27823690
6.
Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy.
Am Heart J
; 180: 82-9, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27659886
7.
Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar.
Catheter Cardiovasc Interv
; 88(2): 163-73, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26698636
8.
Predictors and prognosis of early ischemic mitral regurgitation in the era of primary percutaneous coronary revascularisation.
Cardiovasc Ultrasound
; 12: 14, 2014 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-24708546
9.
Early and late outcomes after primary percutaneous coronary intervention by radial or femoral approach in patients presenting in acute ST-elevation myocardial infarction and cardiogenic shock.
Am Heart J
; 165(3): 338-43, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23453102
10.
Canada Acute Coronary Syndrome Risk Score: a new risk score for early prognostication in acute coronary syndromes.
Am Heart J
; 166(1): 58-63, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23816022
11.
Incidence and clinical impact of concurrent chronic total occlusion according to gender in ST-elevation myocardial infarction.
Catheter Cardiovasc Interv
; 82(1): 19-26, 2013 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23074092
12.
Antithrombotic therapies in Canadian atrial fibrillation patients with concomitant coronary artery disease: Insights from the CONNECT AFâ¯+â¯PCI-II program.
J Cardiol
; 82(2): 153-161, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36931433
13.
Deadly association of cardiogenic shock and chronic total occlusion in acute ST-elevation myocardial infarction.
Am Heart J
; 164(4): 509-15, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23067908
14.
Effects of aspiration thrombectomy on necrosis size and ejection fraction after transradial percutaneous coronary intervention in acute ST-elevation myocardial infarction.
Catheter Cardiovasc Interv
; 77(4): 475-82, 2011 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20578162
15.
Racial Disparities in Acute Coronary Syndrome Management Within a Universal Healthcare Context: Insights From the AMI-OPTIMA Trial.
CJC Open
; 3(12 Suppl): S28-S35, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34993431
16.
Provision of a DAPT Score to Cardiologists and Extension of Dual Antiplatelet Therapy Beyond 1 Year After ACS: Randomized Substudy of the Prospective Canadian ACS Reflective II Study.
CJC Open
; 3(12): 1463-1470, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34993458
17.
Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation: Findings From the CONNECT AF+PCI Study.
CJC Open
; 3(12): 1419-1427, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34993453
18.
Contemporary use of guideline-based higher potency P2Y12 receptor inhibitor therapy in patients with moderate-to-high risk non-ST-segment elevation myocardial infarction: Results from the Canadian ACS reflective II cross-sectional study.
Clin Cardiol
; 44(6): 839-847, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33982795
19.
Comparison of plaque sealing with paclitaxel-eluting stents versus medical therapy for the treatment of moderate nonsignificant saphenous vein graft lesions: the moderate vein graft lesion stenting with the taxus stent and intravascular ultrasound (VELETI) pilot trial.
Circulation
; 120(20): 1978-86, 2009 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-19884468
20.
Management patterns of non-ST segment elevation acute coronary syndromes in relation to prior coronary revascularization.
Am Heart J
; 159(1): 40-6, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20102865